By November 2027, a credible Google Ads retainer will need a ranked test queue, explicit capacity limits, and rules for rejecting new-channel tests. I expect buyers to pay for the judgment behind the next experiment, not the number of platforms an agency can connect.
The scene I keep returning to comes from r/PPC: a bedding brand selling into four countries, roughly $15k a month available for testing, rising CPCs, and customers saying they found it through ChatGPT. The team has 40 people. Everyone is maxed out. Nobody in-house has run ChatGPT ads.
That buyer is not shopping for a platform connection. They are shopping for management bandwidth. The replies to the thread get to the point: distrust confident promises without campaign data, ask for a testing and attribution strategy, and do not pay someone several times your media spend to pretend they are an expert.
The budget exists. The willingness exists. What does not exist is a person with spare hours to learn another ad platform while keeping the first one running.
I spent years as that person: negative-keyword mining at 1am, watching Quality Score tank because someone swapped a landing page without telling me. The mechanical work was demanding. The harder part was deciding, with incomplete data, what deserved attention this week.
Another channel adds another claim on that attention. “We now offer ChatGPT Ads” says nothing about which working campaign gets less scrutiny while the new test runs, or who has the authority to kill it when it disappoints.
The channel is becoming harder to ignore. OpenAI announced in August 2026 that ChatGPT Ads reached a $1 billion annualized run rate in under 200 days, with tens of thousands of advertisers across more than 40 countries. But access does not settle priority.
That is the distinction behind my three predictions. The valuable deliverable is the next decision, not another platform logo on a proposal.
Prediction 1: By November 2027, proposals will lead with a ranked test queue
The credible retainer will open with an experiment queue, not a service menu. Each row will tell the buyer what the team intends to learn, what it will cost, and when someone will make a decision.
Not “we will test ChatGPT Ads.” Something closer to this illustrative proposal:
We will run a $4.8k ChatGPT Ads test against your top two Google Ads non-brand queries for 21 days, judged on cost per booked consultation. At $60 CPA or less, we scale. Above that, we kill it.
The numbers are not a recommendation for every account. The specificity is the point. A buyer can question the budget, challenge the threshold, or reject the hypothesis. “Explore new opportunities” offers nothing to argue with. Convenient for the seller.
A useful queue makes the tradeoffs visible before the money moves. At minimum, I want each experiment to show:
- Hypothesis: what the test is supposed to establish.
- Priority: why it runs before the alternatives.
- Owner: who answers for the decision.
- Budget ceiling and decision date: how much evidence the team is buying, and when it stops buying it.
- Primary metric and guardrails: what counts as success, and what must not deteriorate.
- Outcome: keep, roll back, revise, or continue collecting evidence.
The mechanics already exist. Google’s experiment documentation tells advertisers to start with a clear hypothesis tied to a business goal, test one variable at a time, and choose one or two success metrics before launch. Custom experiments share the original campaign’s budget and traffic, typically at a 50% split.
The platform has supported disciplined testing for years. My prediction is that buyers will increasingly demand to see that discipline before signing, rather than discovering its absence after paying.
A published PPC prioritization framework makes the queue more concrete: qualified conversion rate or cost per qualified lead rather than raw leads, guardrails for volume, quality and profitability, an ICE score, and a recorded outcome. It names the hardest decision as choosing what not to test yet.
That last word matters. A ranked queue is not a promise to run everything eventually. It is an admission that the budget and the team cannot do everything now. The proposal needs to say how much execution capacity exists and what happens when it is full. Otherwise, the queue is a wish list wearing a spreadsheet.
What would prove me wrong by November 2027: major Google Ads agencies still sell retainers through service lists and spend tiers, with no ranked queue, and buyers continue signing without asking for one.
My check is simple: ask for the next three proposed experiments and the reason for their order. Watch what happens to the meeting.
Prediction 2: By November 2027, good retainers will document declined tests
A ranked queue promises to run something. A declined-tests log promises to say no. I expect the retainer worth paying for to include both.
The decline reasons should be unglamorous and specific:
- Tracking cannot separate the channel’s contribution.
- The landing page cannot support the proposed traffic.
- Execution capacity is already committed to a working campaign that would suffer.
“Not a priority” is not enough. I want to know which constraint made it a bad test now. An agency that accepts every experiment has not solved the capacity problem. It has put the problem on your invoice.
ChatGPT Ads shows why a rejection policy matters. A documented agency test that spent $1,524 between June and August 2026 found conversion reporting too limited to answer basic measurement questions at the time. OpenAI announced attribution, analytics and incrementality partner integrations in October 2026, after that test concluded.
Channel access and measurement readiness are different things. A team can have permission to spend without having a useful way to judge the spending. Gate the test on tracking, not just available budget.
The early performance evidence also gives me little patience for confident forecasts. An October 2026 working paper by Kaiser and Schulze followed 102 advertiser sites through OpenAI’s country-by-country rollout. It reported $0.89 in revenue per US visit from a ChatGPT ad against $2.45 for a paid Google search visit, with conversion rates of 0.37% and 1.17%, respectively.
Those figures do not decide what your account will do. They do make “we know exactly what to expect” a difficult sales pitch to defend. OpenAI’s own ads FAQ says ChatGPT Ads does not yet have performance benchmarks across advertisers, industries or campaign types.
The account-level reports are noisy too. A single agency SaaS test put $4,800 into ChatGPT Ads and reported roughly 310k impressions, 8,900 clicks, 620 signups and 87 paid conversions, or about $55 CAC. Another commenter described a $2k test that produced engaged-looking referral traffic in GA4 and zero conversions. A Canadian advertiser running multiple brands reported CPCs matching Google Ads for the same keywords and location, with fewer results.
I do not read that as “never test ChatGPT.” I read it as “earn the test.” Show that the measurement works, the landing page is ready, and the team can run it without neglecting something already productive.
The declines log is the harder sell because it makes restraint visible. A services menu says what the agency can bill for. A documented refusal says what it will protect your budget from.
What would prove me wrong by November 2027: credible retainers still document only completed work, buyers accept verbal explanations for rejected tests, and nobody expects a record of the tradeoff.
Ask which test the agency most recently declined and why. The answer should contain a constraint, not a speech about innovation.
Prediction 3: By November 2027, integrated reports will show what each test displaced
“ChatGPT Ads produced 87 signups” is not enough for me to judge a budget decision. Which Google Ads campaign gave up spend? What did the strategist stop examining while the test ran? What else could that money and attention have done?
A test’s cost includes the opportunity it displaced. My third prediction is that an integrated report will make that cost explicit, rather than treating every new channel as an addition with no consequences.
Recast’s prioritization logic supplies a useful filter: What will I do differently if this test tells me something new? If the answer is nothing, do not run it.
That question belongs before launch. Afterward, the report needs to explain whether the test earned its place ahead of the alternatives.
I want two parts, kept distinct:
- Separate channel results. Show Google Ads and ChatGPT Ads performance on their own, using the measurements available. Do not hide a weak channel inside a blended “total search performance” number.
- Coordinated budget decisions. Show what the $15k test budget is now not doing, why that sacrifice was acceptable, and whether the evidence supports continuing it.
The first part tells me what happened. The second tells me whether the management decision made sense.
This is also where capacity stops being a vague staffing concern. A strategist cannot promise unlimited scrutiny. If launching a new test means a working campaign gets less attention, the buyer should see that tradeoff before launch, not infer it from a disappointing month.
A report that lists results by platform but never explains the allocation decision is not an integrated program. It is three account lists stapled together.
I expect this to matter more as the evidence gets noisier. One encouraging SaaS test does not settle the next account’s priorities. Neither does one failed experiment. The useful question is not whether somebody, somewhere made the channel work. It is whether this test deserves the next slice of your budget and attention.
What would prove me wrong by November 2027: integrated-search reports still lead with channel spend and blended ROAS, omit what new tests displaced, and buyers remain satisfied with that picture.
Ask to see a report where a new test is judged against the thing it replaced. A long pause is diagnostic.
What I would ask a Google Ads agency for today
If these predictions are even half right, the buying conversation changes now. I would ask five questions, in this order:
- What are the next three proposed experiments, and why that order? A service menu is not an answer. I want the queue and the reasoning.
- Who handles execution, and what happens to the working campaigns while a new test runs? The deliverable is a capacity plan, not a headcount slide.
- Which tests have you declined recently, and why? A blank answer does not prove the agency ran everything. It does leave me without evidence that it knows when to stop.
- Can you show me a report that judges a new test against what it replaced? Channel totals alone do not answer an allocation question.
- Who owns the outcome and has the authority to kill a test? I want a name, a call, and someone who can act on Tuesday because the data said so on Monday.
I have been the unnamed person in that last slot. Too often, nothing moved without a meeting to move it. Adding another platform does not fix that arrangement.
This is where groas sits, and I want to be precise about why rather than loud. groas runs paid and organic search as a fully autonomous growth engine: specialized models execute campaign, content, bidding, targeting, budget and optimization work around the clock, while a named senior strategist sets guardrails and owns the outcome. Every change logs its reasoning.
That division addresses the capacity problem directly: continuous execution does not have to wait for someone to clear a block in their calendar, while strategic ownership stays with a named person. A combined groas engagement coordinates Google, Bing and ChatGPT under one strategist rather than adding another retainer and another account list.
The commercial structure follows the same argument: one flat monthly fee, no setup fee, no percentage-of-spend markup, month-to-month cancellation, a live free trial and a 7-day money-back guarantee. More spend does not mean a larger management percentage.
One flat fee still does not make every test worth running. groas declines work too. Its action log records changes, their reasoning and anything that failed; I would still ask directly for the reasoning behind a declined test. An execution record and a rejection decision answer different questions.
Before committing, the groas free tools offer a place to start. The Google Ads Grader reads a search terms report and shows how much spend went to searches that never converted. The conversion tracking checker runs from a URL without account access. Those are useful questions to answer before buying more traffic anywhere.
The failure mode I keep coming back to is not a bad keyword list. It is a team with money, willingness and no capacity for the next decision: four countries, rising CPCs, customers mentioning ChatGPT, and $15k a month waiting for someone with the hours and judgment to spend it well.
If you want to see a test queue before signing anything, book a consultation and a senior strategist will study your numbers before the call. For the same falsifiable-prediction treatment of Bing Ads buying, read my 2028 bet on Bing agencies.
And if you are the person from that r/PPC thread: put three tests in order, attach budgets and decision dates, and decline the rest for now. By November 2027, I expect every good retainer to make that discipline visible. Ask for it before you sign.

